These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7952606)

  • 1. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
    Jones BE; Otaya M; Antoniskis D; Sian S; Wang F; Mercado A; Davidson PT; Barnes PF
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1499-502. PubMed ID: 7952606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s.
    Van Schalkwyk M; Bekker A; Decloedt E; Wang J; Theron GB; Cotton MF; Eke AC; Cressey TR; Shapiro DE; Bacon K; Knowles K; George K; Browning R; Chakhtoura N; Rungruengthanakit K; Wiesner L; Capparelli EV; Stek AM; Mirochnick M; Best BM;
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0073723. PubMed ID: 37882552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trial.
    Hissar S; Velayutham B; Tamizhselvan M; Rathinam S; Arunbabu C; Vidhya JB; Vargunapandian G; Sundararajaperumal A; Sivaramakrishnan GN; Chelvi S; Ramesh PM; Arun D; Reddy SD; Kumaran PP; Kumar MM; Kalaiselvi D; Hanna LE; Kumar H; Gowrisankar A; Rajavelu R; Jayabal L; Ponnuraja C; Baskaran D
    BMC Infect Dis; 2024 Jul; 24(1):729. PubMed ID: 39054415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
    Namasivayam S; Maiga M; Yuan W; Thovarai V; Costa DL; Mittereder LR; Wipperman MF; Glickman MS; Dzutsev A; Trinchieri G; Sher A
    Microbiome; 2017 Jul; 5(1):71. PubMed ID: 28683818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of thrombocytopenia caused by rifampicin and pyrazinamide.
    Bansal R; Sharma PK; Sharma A
    Indian J Pharmacol; 2013; 45(4):405-7. PubMed ID: 24014922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torticollis in mice intravenously infected with Mycobacterium tuberculosis.
    Magden ER; Weiner CM; Gilliland JC; DeGroote MA; Lenaerts AJ; Kendall LV
    J Am Assoc Lab Anim Sci; 2011 Mar; 50(2):244-7. PubMed ID: 21439219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A complex case study: coexistence of multi-drug-resistant pulmonary tuberculosis, HBV-related liver failure, and disseminated cryptococcal infection in an AIDS patient.
    Fu W; Deng ZW; Wang P; Zhu ZW; Pu Y; Xie ZB; Li YZ; Yu HY
    BMC Infect Dis; 2024 May; 24(1):533. PubMed ID: 38802753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of active pulmonary tuberculosis in adults: current standards and recent advances. Insights from the Society of Infectious Diseases Pharmacists.
    Hall RG; Leff RD; Gumbo T
    Pharmacotherapy; 2009 Dec; 29(12):1468-81. PubMed ID: 19947806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil.
    Damasceno GS; Guaraldo L; Engstrom EM; Theme Filha MM; Souza-Santos R; Vasconcelos AG; Rozenfeld S
    Clinics (Sao Paulo); 2013; 68(3):329-37. PubMed ID: 23644852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient on RIPE therapy presenting with recurrent isoniazid-associated pleural effusions: a case report.
    Varenika V; Blanc PD
    J Med Case Rep; 2011 Nov; 5():558. PubMed ID: 22129471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of second-line tuberculosis treatment in migrants from Vietnam. International Organization for Migration (IOM) Tuberculosis Working Group.
    Trop Med Int Health; 1998 Dec; 3(12):975-80. PubMed ID: 9892282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe arthropathy with ofloxacin in two cases of MDR tuberculosis.
    Arora VK; Tumbanatham A
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):941-3. PubMed ID: 9848618
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal primary multidrug-resistant tuberculosis in a heart transplant recipient.
    Di Perri G; Luzzati R; Forni A; Allegranzi B; Cazzadori A; Bonora S; Mazzucco A; Concia E
    Transpl Int; 1998; 11(4):305-7. PubMed ID: 9704397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple drug-resistant tuberculosis.
    Bradford WZ; Daley CL
    Infect Dis Clin North Am; 1998 Mar; 12(1):157-72. PubMed ID: 9494836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant tuberculosis in Denmark 1993-1995.
    Viskum K; Kok-Jensen A
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):299-301. PubMed ID: 9432383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.
    Kritski AL; Rodrigues de Jesus LS; Andrade MK; Werneck-Barroso E; Vieira MA; Haffner A; Riley LW
    Chest; 1997 May; 111(5):1162-7. PubMed ID: 9149564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faulty prescription--an avoidable cause of multidrug resistance tuberculosis.
    Jain RF
    J Indian Med Assoc; 1996 Oct; 94(10):385-8. PubMed ID: 9141879
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.